Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus

• Justin D. Hoopes,

  Affiliation Adamas Pharmaceuticals, Inc., Emeryville, California, United States of America

  ⨯
• Elizabeth M. Driebe,

  Affiliation Translational Genomics Research Institute, Flagstaff, Arizona, United States of America

  ⨯
• Erin Kelley,

  Affiliation Translational Genomics Research Institute, Flagstaff, Arizona, United States of America

  ⨯
• David M. Engelthaler,

  Affiliation Translational Genomics Research Institute, Flagstaff, Arizona, United States of America

  ⨯
• Paul S. Keim,

  Affiliation Translational Genomics Research Institute, Flagstaff, Arizona, United States of America

  ⨯
• Alan S. Perelson,

  Affiliation Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America

  ⨯
• Libin Rong,

  Affiliation Oakland University, Rochester, Michigan, United States of America

  ⨯
• Gregory T. Went,

  Affiliation Adamas Pharmaceuticals, Inc., Emeryville, California, United States of America

  ⨯
• Jack T. Nguyen

  * E-mail: jnguyen@adamaspharma.com

  Affiliation Adamas Pharmaceuticals, Inc., Emeryville, California, United States of America

  ⨯